Pharmabiz

Esaote & Schiller Americas announce strategic partnership to expand the sales channel in the cardiology imaging space

Esaote & Schiller Americas announce strategic partnership to expand the sales channel in the cardiology imaging space: ...
Pharmabiz

Sarepta Therapeutics reports US FDA’s approval of updated Elevidys prescribing information

Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, announced an update to the prescribing information for Elevidys (delandistrogene moxeparvovec-rokl), the only ...
Pharmabiz

Alembic Pharma receives US FDA final approval for diltiazem HCl tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg

Alembic Pharma receives US FDA final approval for diltiazem HCl tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg: Our Bureau, Mumbai Monday, November 17, 2025, 13:30 Hrs [IST] Alembic ...
Pharmabiz

Adagene inks licensing agreement with Third Arc Bio to develop two masked CD3 T cell engagers utilizing SAFEbody technology

Adagene inks licensing agreement with Third Arc Bio to develop two masked CD3 T cell engagers utilizing SAFEbody technology: San Diego Monday, November 17, 2025, 14:00 Hrs [IST] A ...
Pharmabiz

NORD launches new request for proposals for patient registries

NORD launches new request for proposals for patient registries: Danbury, Connecticut Monday, November 17, 2025, 15:00 Hrs [IST] The National Organization for Rare Disorders (NORD) ...
Pharmabiz

Rejection of trial waiver for Hetero's generic HIV drug will impact India & other LMICs: TWN

Rejection of trial waiver for Hetero's generic HIV drug will impact India & other LMICs: TWN: Our Bureau, New Delhi Monday, November 17, 2025, 12:10 Hrs [IST] The decision of the ...
Pharmabiz

Bristol Myers Squibb and Johnson & Johnson to discontinue phase 3 Librexia ACS trial of milvexian treat acute coronary syndrome

Bristol Myers Squibb and Johnson & Johnson to discontinue phase 3 Librexia ACS trial of milvexian treat acute coronary syndrome: Princeton, New Jersey Monday, November 17, 2025, 1 ...
Pharmabiz

WHO promotes lifesaving intervention for small and preterm babies on first official World Prematurity Day

WHO promotes lifesaving intervention for small and preterm babies on first official World Prematurity Day: Geneva Monday, November 17, 2025, 10:00 Hrs [IST] The World Health Organ ...
Pharmabiz

EMA committee recommends marketing approval for Waskyra, a gene therapy to treat Wiskott-Aldrich syndrome

EMA committee recommends marketing approval for Waskyra, a gene therapy to treat Wiskott-Aldrich syndrome: Rome Monday, November 17, 2025, 11:00 Hrs [IST] Fondazione Telethon, an ...
Pharmabiz

Govt aims to set up more AMRIT Pharmacies across the country, says Union health minister

Govt aims to set up more AMRIT Pharmacies across the country, says Union health minister: Our Bureau, New Delhi Monday, November 17, 2025, 09:00 Hrs [IST] While every AIIMS in the ...
Pharmabiz

India is a strategic innovation engine for lifes ciences with advances in data science & AI: Michael Schmidt

Nandita Vijayasimha, Bengaluru Monday, November 17, 2025, 08:00 Hrs [IST] ...
Pharmabiz

ICMR lists important pathogens causing critical infections to guide public health policies and biomedical research

ICMR lists important pathogens causing critical infections to guide public health policies and biomedical research: Shardul Nautiyal, Mumbai Monday, November 17, 2025, 08:00 Hrs [ ...